Novanta (NOVT) CEO sells 6,500 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

Novanta Inc. Chief Executive Officer Matthijs Glastra reported open-market sales of 6,500 shares of common stock on March 2, 2026. The shares were sold in multiple transactions at prices ranging from $131.92 to $140.48 per share under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025. Following these sales, he holds 63,261 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glastra Matthijs

(Last) (First) (Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD MA 01730

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S(1)		49	D	$131.92	69,712	D
Common Stock	03/02/2026		S(1)		500	D	$133.77(2)	69,212	D
Common Stock	03/02/2026		S(1)		74	D	$134.69(3)	69,138	D
Common Stock	03/02/2026		S(1)		586	D	$136.35(4)	68,552	D
Common Stock	03/02/2026		S(1)		1,375	D	$137.28(5)	67,177	D
Common Stock	03/02/2026		S(1)		940	D	$138.67(6)	66,237	D
Common Stock	03/02/2026		S(1)		1,180	D	$139.5(7)	65,057	D
Common Stock	03/02/2026		S(1)		1,796	D	$140.48(8)	63,261	D
Common Stock								54,382	I	Matthijs Glastra 2021 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

2. This transaction was executed in multiple trades ranging from $133.03 to $133.96. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades ranging from $134.52 to $134.98. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades ranging from $135.86 to $136.86. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades ranging from $136.89 to $137.79. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades ranging from $137.90 to $138.84. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades ranging from $138.96 to $139.96. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades ranging from $140.08 to $140.75. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NOVANTA INC (NOVT) disclose for Matthijs Glastra?

NOVANTA INC disclosed that CEO Matthijs Glastra sold 6,500 shares of common stock in open-market transactions. The sales occurred on March 2, 2026, across several trades at different prices as part of an established Rule 10b5-1 trading plan.

At what prices did the NOVT CEO sell his Novanta shares?

The CEO’s Novanta share sales were executed at prices between $131.92 and $140.48 per share. These were multiple open-market transactions on March 2, 2026, with several trades contributing to the total 6,500 shares sold.

How many Novanta (NOVT) shares does the CEO hold after the reported sales?

After the reported sales, the CEO holds 63,261 Novanta common shares directly. He also has indirect ownership of 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust, according to the Form 4 filing details.

Was the NOVANTA INC CEO’s stock sale under a Rule 10b5-1 trading plan?

Yes, the Form 4 states the CEO’s stock sales were effected under a pre-established Rule 10b5-1 trading plan. This plan was adopted on September 11, 2025, through a trust for which the reporting person’s spouse serves as trustee.

How many Novanta (NOVT) shares did the CEO sell in total on March 2, 2026?

The CEO sold a total of 6,500 Novanta common shares on March 2, 2026. This total reflects eight separate open-market sale transactions reported in the Form 4, each with its own share amount and execution price.

What indirect Novanta share ownership is reported for the CEO on the Form 4?

The Form 4 reports indirect ownership of 54,382 Novanta shares for the CEO. These shares are held through the Matthijs Glastra 2021 Irrevocable Trust, indicating a separate indirect holding in addition to his directly owned shares.